Skip to main content
. 2017 May 15;2017(5):CD011673. doi: 10.1002/14651858.CD011673.pub2

Analysis 1.3.

Analysis 1.3

Comparison 1 Interferon‐α (IFN‐α) alone versus standard targeted therapies in first‐line therapy of metastatic renal cell carcinoma, Outcome 3 Quality of life.